Skip to Content
Merck
All Photos(1)

Documents

D2000000

Dimenhydrinate

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

N-(2-Diphenylmethoxyethyl)-N,N-dimethylammonium 8-chlorotheophyllinate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H21NO · C7H7ClN4O2
CAS Number:
523-87-5
Molecular Weight:
469.96
MDL number:
MFCD00054265
UNSPSC Code:
41116107
PubChem Substance ID:
329798724
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

dimenhydrinate

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

CN1C(=O)N(C)c2nc(Cl)[nH]c2C1=O.CN(C)CCOC(c3ccccc3)c4ccccc4

InChI

1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)

InChI key

NFLLKCVHYJRNRH-UHFFFAOYSA-N

Gene Information

human ... HRH1(3269)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Dimenhydrinate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

PHR1009

Caffeine, Pharmaceutical Secondary Standard; Certified Reference Material

1085003

Caffeine, United States Pharmacopeia (USP) Reference Standard

C0100000

Caffeine, European Pharmacopoeia (EP) Reference Standard

Y0001103

Dimenhydrinate for peak identification, European Pharmacopoeia (EP) Reference Standard

1206006

Dimenhydrinate, United States Pharmacopeia (USP) Reference Standard

1206017

Dimenhydrinate Related Compound E, United States Pharmacopeia (USP) Reference Standard

PHR1658

Dimenhydrinate, Pharmaceutical Secondary Standard; Certified Reference Material

BP766

Caffeine, British Pharmacopoeia (BP) Reference Standard

BP1119

Diphenylmethanol, British Pharmacopoeia (BP) Reference Standard

PHR2117

4,4′-Difluorobenzophenone, Pharmaceutical Secondary Standard; Certified Reference Material

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Precautionary Statements

P301 + P312 + P330

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Alison G Halpert et al.
Neuroscience and biobehavioral reviews, 26(1), 61-67 (2002-02-12)
The over-the-counter anti-emetic dimenhydrinate (DMH) (Gravol or Dramamine) has been reported to be abused for non-medicinal purposes. Street drug users abuse DMH for the acute effects of euphoric sensations and hallucinations, while psychiatric patients abuse DMH for its anxiolytic or
Min-Beom Kim et al.
The Laryngoscope, 124(10), 2400-2403 (2014-05-02)
To investigate the characteristics of residual symptoms and to evaluate the effects of adjuvant vestibular suppressants on residual symptoms after successful canalith repositioning procedures (CRPs). Individual randomized controlled trial. One hundred fifty patients with idiopathic benign paroxysmal positional vertigo who
Cristiane Effting et al.
Therapeutic drug monitoring, 37(1), 66-70 (2015-01-15)
Busulfan is an alkylating agent used for conditioning patients undergoing hematopoietic stem cell transplantation with a narrow therapeutic range and highly variable pharmacokinetics. High concentrations induce toxicity, especially hepatic veno-occlusive disease, also referred to as sinusoidal obstruction syndrome. This study

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service